4.7 Article

17 alpha-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/gerona/glv309

关键词

17 alpha-Estradiol; Adipose tissue; Hypothalamus; Inflammation; Metabolism

资金

  1. National Institutes of Health [P01 AG041122]
  2. Robert and Arlene Kogod Career Development Award in Aging Research
  3. Minnesota Obesity Center [P30 DK050456]
  4. FAPESP [2015/05801-7]
  5. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER
  6. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111121] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099402] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE ON AGING [K99AG051661, R37AG013925, P01AG041122, F30AG046061] Funding Source: NIH RePORTER
  9. Biotechnology and Biological Sciences Research Council [BB/I020748/1] Funding Source: researchfish
  10. BBSRC [BB/I020748/1] Funding Source: UKRI

向作者/读者索取更多资源

Aging is associated with visceral adiposity, metabolic disorders, and chronic low-grade inflammation. 17 alpha-estradiol (17 alpha-E2), a naturally occurring enantiomer of 17 beta-estradiol (17 beta-E2), extends life span in male mice through unresolved mechanisms. We tested whether 17 alpha-E2 could alleviate age-related metabolic dysfunction and inflammation. 17 alpha-E2 reduced body mass, visceral adiposity, and ectopic lipid deposition without decreasing lean mass. These declines were associated with reductions in energy intake due to the activation of hypothalamic anorexigenic pathways and direct effects of 17 alpha-E2 on nutrient-sensing pathways in visceral adipose tissue. 17 alpha-E2 did not alter energy expenditure or excretion. Fasting glucose, insulin, and glycosylated hemoglobin were also reduced by 17 alpha-E2, and hyperinsulinemic-euglycemic clamps revealed improvements in peripheral glucose disposal and hepatic glucose production. Inflammatory mediators in visceral adipose tissue and the circulation were reduced by 17 alpha-E2. 17 alpha-E2 increased AMPK alpha and reduced mTOR complex 1 activity in visceral adipose tissue but not in liver or quadriceps muscle, which is in contrast to the generalized systemic effects of caloric restriction. These beneficial phenotypic changes occurred in the absence of feminization or cardiac dysfunction, two commonly observed deleterious effects of exogenous estrogen administration. Thus, 17a-E2 holds potential as a novel therapeutic for alleviating age-related metabolic dysfunction through tissue-specific effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据